Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.51 |
| ▸ | GSR | P00390 | 1/20 | 0.47 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.46 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
| ▸ | CPB2 | Q96IY4 | 9/20 | 0.42 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.41 |
| ▸ | ACE | P12821 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1116199 | 1.00 | FOLH1 (0.51) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| SCHEMBL29741342 | 1.00 | FOLH1 (0.51) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| SCHEMBL5869685 | 0.94 | FOLH1 (0.45) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| SCHEMBL8254457 | 0.94 | FOLH1 (0.45) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| SCHEMBL1413149 | 0.87 | FOLH1 (0.53) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| SCHEMBL209237 | 0.87 | FOLH1 (0.53) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| SCHEMBL3727817 | 0.87 | FOLH1 (0.53) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| Leucine SCHEMBL8340593 | 0.87 | SLC7A5 (0.50) | FOLH1GSRSLC6A5CPB2 | |
| SCHEMBL10939912 | 0.86 | FOLH1 (0.46) | FOLH1GSRRNPEPSLC6A5MMP2 | |
| SCHEMBL23451044 | 0.85 | FOLH1 (0.51) | FOLH1GSRRNPEPSLC6A5MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 659 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026100584-A1 | BEER-FLAVORED BEVERAGE AND METHOD FOR PRODUCING SAME | キリンホールディングス株式会社 | 2026-05-15 | — | — | WO | claimed |
| US-20250250331-A1 | ANTI-AGE ANTIBODIES FOR TREATING NEURODEGENERATIVE DISORDERS | SIWA CORP (US) | 2025-08-07 | — | — | US | claimed |
| WO-2025083830-A1 | NON-ALCOHOLIC BEER-FLAVORED BEVERAGE HAVING ENHANCED RICHNESS | キリンホールディングス株式会社 | 2025-04-24 | — | — | WO | claimed |
| CN-119331874-A | Carboxymethyl lysine and carboxyethyl lysine aptamer based on efficient microfluidic SELEX platform screening | 江南大学 | 2025-01-21 | — | — | CN | claimed |
| WO-2025005235-A1 | BEER-FLAVORED ALCOHOLIC BEVERAGE AND METHOD FOR PRODUCING SAME | キリンホールディングス株式会社 | 2025-01-02 | — | — | WO | claimed |
| CN-118879581-A | Lactobacillus plantarum (Lactiplantibacillus plantarum) NKU SS120, culture and application | 南开大学 | 2024-11-01 | — | — | CN | claimed |
| WO-2024225456-A1 | BEER-FLAVORED ALCOHOLIC BEVERAGE AND PRODUCTION METHOD THEREFOR | キリンホールディングス株式会社 | 2024-10-31 | — | — | WO | claimed |
| US-20240329058-A1 | BIOMARKER FOR NEURODEGENERATIVE DISEASES COMPRISING GLYCOTOXIN, SPECIFIC PROTEIN BOUND TO GLYCOTOXIN, OR GLYCOTOXIN-SPECIFIC PROTEIN COMPLEX | GACHON UNIVERSITY OF INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2024-10-03 | — | — | US | claimed |
| US-12044684-B2 | Methods for diagnosing an autistic spectrum disorder | QATAR UNIVERSITY (QA) | 2024-07-23 | — | — | US | claimed |
| EP-4388016-A1 | METHODS AND COMPOSITIONS FOR TREATING FIBROTIC DISEASES | Siwa Corporation (US) | 2024-06-26 | — | — | EP | claimed |
| WO-2011113607-A1 | MOLECULARLY IMPRINTED POLYMERS FOR ELIMINATING METABOLITES | FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH (DE) | 2011-09-22 | — | — | WO | claimed |
| EP-2124934-A2 | COSMETIC AND PHARMACEUTICAL APPLICATIONS OF N-ACETYLHYDROXYPROLINE | Beiersdorf AG (DE) | 2009-12-02 | — | — | EP | claimed |
| EP-2117536-A2 | COSMETIC AND PHARMACEUTICAL APPLICATIONS OF N-ACYLATED AMINO ACIDS AND STRUCTURALLY RELATED COMPOUNDS | Beiersdorf AG (DE) | 2009-11-18 | — | — | EP | claimed |
| WO-2008101692-A2 | COSMETIC AND PHARMACEUTICAL APPLICATIONS OF N-ACETYLHYDROXYPROLINE | BEIERSDORF AG (DE) | 2008-08-28 | — | — | WO | claimed |
| WO-2008101693-A2 | COSMETIC AND PHARMACEUTICAL APPLICATIONS OF N-ACYLATED AMINO ACIDS AND STRUCTURALLY RELATED COMPOUNDS | BEIERSDORF AG (DE) | 2008-08-28 | — | — | WO | claimed |
| WO-2005037990-A2 | USE OF PARP INHIBITORS FOR PREVENTION AND TREATMENT OF DIABETIC AND INSULIN RESISTANCE COMPLICATIONS | ALBERT EINSTEIN COLLEGE OF MEDECINE OF YESHIVA UNIVERSITY (US) | 2005-04-28 | — | — | WO | claimed |
| EP-1023080-A4 | LIGAND BINDING SITE OF RAGE AND USES THEREOF | UNIV COLUMBIA (US) | 2003-03-19 | — | — | EP | claimed |
| US-20010053357-A1 | LIGAND BINDING SITE OF RAGE AND USES THEREOF | TRANSTECH PHARMA, INC. | 2001-12-20 | — | — | US | claimed |
| EP-1023080-A1 | LIGAND BINDING SITE OF RAGE AND USES THEREOF | The Trustees of Columbia University in the City of New York (US) | 2000-08-02 | — | — | EP | claimed |
| WO-1999018987-A1 | LIGAND BINDING SITE OF RAGE AND USES THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1999-04-22 | — | — | WO | claimed |